Oluwatayo Ikotun*

/in /by

Publications:

Chan AM, Olafsen T, Tsui J, Salazar FB, Aguirre B, Zettlitz KA, Condro M, Wu AM, Braun J, Gordon LK, Ashki N, Whitelegge J, Xu S, Ikotun O, Lee JT, Wadehra M. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Mol Cancer Ther. 2024 Jun 04; 23(6):890-903. view on PubMed

Moesta AK, Cooke K, Piasecki J, Mitchell P, Rottman JB, Fitzgerald K, Zhan J, Yang B, Le T, Belmontes B, Ikotun OF, Merriam K, Glaus C, Ganley K, Cordover DH, Boden AM, Ponce R, Beers C, Beltran PJ. Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade. Clin Cancer Res. 2017 Oct 15; 23(20):6190-6202. view on PubMed

Marquez BV, Ikotun OF, Zheleznyak A, Wright B, Hari-Raj A, Pierce RA, Lapi SE. Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts. Mol Pharm. 2014 Nov 03; 11(11):3988-95. view on PubMed

Ikotun OF, Marquez BV, Fazen CH, Kahkoska AR, Doyle RP, Lapi SE. Investigation of a vitamin B12 conjugate as a PET imaging probe. ChemMedChem. 2014 Jun; 9(6):1244-51. view on PubMed

Marquez BV, Ikotun OF, Parry JJ, Rogers BE, Meares CF, Lapi SE. Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor. J Nucl Med. 2014 Jun; 55(6):1029-34. view on PubMed

Zheleznyak A, Ikotun OF, Dimitry J, Frazier WA, Lapi SE. Imaging of CD47 expression in xenograft and allograft tumor models. Mol Imaging. 2013 Nov-Dec; 12(8). view on PubMed

Ikotun OF, Marquez BV, Huang C, Masuko K, Daiji M, Masuko T, McConathy J, Lapi SE. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET. PLoS One. 2013; 8(10):e77476. view on PubMed

Ikotun OF, Lapi SE. The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86. Future Med Chem. 2011 Apr; 3(5):599-621. view on PubMed